Vicus Capital lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 44.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,930 shares of the company’s stock after selling 2,330 shares during the quarter. Vicus Capital’s holdings in Procter & Gamble were worth $508,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Steele Capital Management Inc. purchased a new stake in shares of Procter & Gamble in the first quarter valued at approximately $204,000. GAMMA Investing LLC lifted its holdings in shares of Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the period. Consilio Wealth Advisors LLC grew its position in shares of Procter & Gamble by 27.7% during the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock worth $283,000 after buying an additional 379 shares in the last quarter. AMF Tjanstepension AB raised its holdings in shares of Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after acquiring an additional 1,466,115 shares in the last quarter. Finally, Talbot Financial LLC lifted its stake in Procter & Gamble by 1.5% in the first quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock worth $10,644,000 after acquiring an additional 950 shares during the period. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
Shares of NYSE:PG traded up $0.82 on Tuesday, hitting $170.36. 2,762,308 shares of the company were exchanged, compared to its average volume of 6,667,838. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The stock’s 50 day moving average price is $171.82 and its 200 day moving average price is $167.33. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The firm has a market capitalization of $402.07 billion, a P/E ratio of 27.76, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.36%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.
Insider Activity
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the sale, the chief executive officer now directly owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the sale, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock valued at $65,140,718 in the last ninety days. Insiders own 0.17% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on PG. BNP Paribas initiated coverage on shares of Procter & Gamble in a report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price target for the company. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday. Piper Sandler started coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective for the company. Finally, DA Davidson lifted their target price on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $177.00.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- What is the NASDAQ Stock Exchange?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Canadian Penny Stocks: Can They Make You Rich?
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Overbought Stocks Explained: Should You Trade Them?
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.